Published in Cochrane Database Syst Rev on January 23, 2008
Beijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam. Antimicrob Agents Chemother (2009) 1.70
A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis. Bioorg Med Chem Lett (2013) 1.25
Research questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analyses. PLoS One (2012) 1.09
Outcome of hospitalized MDR-TB patients: Israel 2000-2005. Eur J Clin Microbiol Infect Dis (2010) 0.89
Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation. BMC Cancer (2015) 0.86
New Antituberculosis Drugs: From Clinical Trial to Programmatic Use. Infect Dis Rep (2016) 0.81
Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia. Crit Care (2012) 0.79
Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis. PLoS One (2015) 0.79
Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients. Antimicrob Agents Chemother (2016) 0.75
[Proposal of anti-tuberculosis regimens based on susceptibility to isoniazid and rifampicin]. Rev Peru Med Exp Salud Publica (2013) 0.75
Evaluation of microscope condition in Malawi. Trans R Soc Trop Med Hyg (2000) 3.03
The operation, quality and costs of a district hospital laboratory service in Malawi. Trans R Soc Trop Med Hyg (2004) 2.84
'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence. Int J Tuberc Lung Dis (2001) 1.92
A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis (2011) 1.79
A one-day method for the diagnosis of pulmonary tuberculosis in rural Ethiopia. Int J Tuberc Lung Dis (2006) 1.61
Relationship between herpes simplex virus ulceration and CD4+ cell counts in patients with HIV infection. AIDS (1992) 1.56
Using a bus service for transporting sputum specimens to the Central Reference Laboratory: effect on the routine TB culture service in Malawi. Int J Tuberc Lung Dis (2004) 1.55
Early diagnosis of HIV infection. Br J Hosp Med (1990) 1.51
Screening pulmonary tuberculosis suspects in Malawi: testing different strategies. Trans R Soc Trop Med Hyg (1997) 1.48
What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence? Int J Tuberc Lung Dis (2001) 1.44
The tuberculosis pandemic: implications for health in the tropics. Trans R Soc Trop Med Hyg (1999) 1.43
Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools. Int J Tuberc Lung Dis (2010) 1.40
Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials. BMJ (1998) 1.34
Characteristics, management and outcome of patients with recurrent tuberculosis under routine programme conditions in Malawi. Int J Tuberc Lung Dis (2003) 1.27
The tuberculosis pandemic--which way now? J Infect (1999) 1.24
Strengthening "DOTS" through community care for tuberculosis. BMJ (1997) 1.22
Simple measures are as effective as invasive techniques in the diagnosis of pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis (2009) 1.20
The clinical impact of nucleic acid amplification tests on the diagnosis and management of tuberculosis in a British hospital. Thorax (2007) 1.19
Quality assessment of sputum transportation, smear preparation and AFB microscopy in a rural district in Malawi. Int J Tuberc Lung Dis (2002) 1.16
Fully intermittent dosing with drugs for treating tuberculosis in adults. Cochrane Database Syst Rev (2001) 1.13
Developing a socio-economic measure to monitor access to tuberculosis services in urban Lilongwe, Malawi. Int J Tuberc Lung Dis (2007) 1.13
Providing HIV care for tuberculosis patients in sub-Saharan Africa. Int J Tuberc Lung Dis (2006) 1.13
Osteomalacia and coeliac disease presenting as isolated dactylitis. Ann Rheum Dis (1988) 1.08
Lymphocyte activation in HIV-1 infection. I. Predominant proliferative defects among CD45R0+ cells of the CD4 and CD8 lineages. AIDS (1993) 1.07
Comparison of scanty AFB smears against culture in an area with high HIV prevalence. Int J Tuberc Lung Dis (2005) 1.05
A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. Int J Tuberc Lung Dis (2011) 1.02
The role of health economics research in implementation research for health systems strengthening. Int J Tuberc Lung Dis (2011) 0.99
New methods in the diagnosis and management of cerebral toxoplasmosis associated with the acquired immune deficiency syndrome. J Infect (1991) 0.98
Pneumocystis carinii pneumonia in patients being registered for smear-negative pulmonary tuberculosis in Malawi. Trans R Soc Trop Med Hyg (2001) 0.97
The bleach microscopy method and case detection for tuberculosis control. Int J Tuberc Lung Dis (2006) 0.97
Performance of the Xpert® MTB/RIF assay in an active case-finding strategy: a pilot study from Tanzania. Int J Tuberc Lung Dis (2012) 0.96
Malaria prevention for travelers. JAMA (1998) 0.95
Efficacy and safety of short-term bleach digestion of sputum in case-finding for pulmonary tuberculosis in Ethiopia. Int J Tuberc Lung Dis (2003) 0.93
Doubts about DOTS. BMJ (2008) 0.92
Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults. J Infect Dis (2001) 0.89
Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis (2000) 0.89
Mobilising the world for chronic NCDs. Lancet (2010) 0.88
Short-term bleach digestion of sputum in the diagnosis of pulmonary tuberculosis in patients co-infected with HIV. Tuberculosis (Edinb) (2007) 0.84
Alveolar macrophage populations are distorted in immunocompromised patients with pneumonitis. Eur Respir J (1992) 0.83
Screening for pulmonary tuberculosis: an acceptable intervention for antenatal care clients and providers? Int J Tuberc Lung Dis (2006) 0.83
Are intestinal helminths a risk factor for non-typhoidal Salmonella bacteraemia in adults in Africa who are seropositive for HIV? A case-control study. Ann Trop Med Parasitol (2002) 0.83
Microbiological validation of smear microscopy after sputum digestion with bleach; a step closer to a one-stop diagnosis of pulmonary tuberculosis. Tuberculosis (Edinb) (2005) 0.82
Hypoadrenalism is not associated with early mortality during tuberculosis treatment in Malawi. Int J Tuberc Lung Dis (2008) 0.80
Antiretroviral treatment reverses HIV-induced reduction in the expression of surface antigens on alveolar macrophages in AIDS patients. Clin Exp Immunol (1993) 0.80
Informed consent. British institutions collaborating in projects overseas may face dilemma. BMJ (1997) 0.80
Lessons to be learned from tuberculosis control in China. Lancet (1996) 0.79
Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev (2005) 0.78
Fully intermittent dosing with drugs for tuberculosis. Cochrane Database Syst Rev (2000) 0.77
Unrecognised Mycobacterium tuberculosis. Lancet (2000) 0.77
Bloody diarrhoea of adults in Malawi: clinical features, infectious agents, and antimicrobial sensitivities. Trans R Soc Trop Med Hyg (1996) 0.76
Pneumothorax and aerosolised pentamidine prophylaxis. Lancet (1991) 0.75
AIDS in Africa: face the facts. Br J Hosp Med (1997) 0.75
NCD Alliance responds to Iona Heath. BMJ (2011) 0.75
HIV infection in a long-term renal transplant recipient. Int J STD AIDS (1995) 0.75
The politics of TB: TB control services need tailoring for new arrivals, not vice versa. Chron Respir Dis (2008) 0.75
Bleach-digested sputum smears for the diagnosis of TB in HIV-infected individuals. Trop Doct (2007) 0.75
Teaching tuberculosis control to medical undergraduates: the Malawi experience. Int J Tuberc Lung Dis (2003) 0.75
Fully intermittent dosing with drugs for tuberculosis. Cochrane Database Syst Rev (2000) 0.75